0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Kidney Cancer Market Insights, Forecast to 2029
Published Date: September 2023
|
Report Code: QYRE-Auto-38R2107
Home | Market Reports | Health| Health Conditions| Cancer
Global Kidney Cancer Market Insights Forecast to 2028
BUY CHAPTERS

Global Kidney Cancer Market Insights, Forecast to 2029

Code: QYRE-Auto-38R2107
Report
September 2023
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Kidney Cancer Market Size

The global Kidney Cancer market is projected to grow from US$ 487.2 million in 2023 to US$ 703.7 million by 2029, at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period.

Kidney Cancer Market

Kidney Cancer Market

Market Analysis and Insights: Global Kidney Cancer Market
Global key players of Kidney Cancer include Pfizer, Exelixis, Bristol-Myers Squibb, Novartis, etc. Global top four manufacturers hold a share over 35%. North America has the largest number of Kidney cancer, holds a share of about 50%. In terms of product, targeted therapy is the largest segment, with a share over 45%. And in terms of application, the largest application is renal cell carcinoma, with a share of over 90%.
Report Includes
This report presents an overview of global market for Kidney Cancer market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Kidney Cancer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Kidney Cancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Kidney Cancer revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Kidney Cancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Kidney Cancer revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer and Exelixis, etc.

Scope of Kidney Cancer Market Report

Report Metric Details
Report Name Kidney Cancer Market
Accounted market size in 2023 US$ 487.2 million
Forecasted market size in 2029 US$ 703.7 million
CAGR 6.3
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Surgery
  • Immunotherapy
  • Targeted Therapy
  • Other
Segment by Application
  • Renal Cell Carcinoma
  • Renal Pelvis Cancer
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Kidney Cancer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Kidney Cancer companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kidney Cancer revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Kidney Cancer Market growing?

Ans: The Kidney Cancer Market witnessing a CAGR of 6.3 during the forecast period 2023-2029.

What is the Kidney Cancer Market size in 2029?

Ans: The Kidney Cancer Market size in 2029 will be US$ 703.7 million.

What is the market share of major companies in Kidney Cancer Market?

Ans: Global top four manufacturers hold a share over 35%.

What is the Kidney Cancer Market share by region?

Ans: North America has the largest number of Kidney cancer, holds a share of about 50%.

What is the Kidney Cancer Market share by type?

Ans: In terms of product, targeted therapy is the largest segment, with a share over 45%.

What is the Kidney Cancer Market share by application?

Ans: And in terms of application, the largest application is renal cell carcinoma, with a share of over 90%.

Who are the main players in the Kidney Cancer Market report?

Ans: The main players in the Kidney Cancer Market are Merck, Novartis, Bristol-Myers Squibb, Pfizer, Roche, Amgen, Aveo Pharmaceuticals, Bayer, Exelixis, Eisai

What are the Application segmentation covered in the Kidney Cancer Market report?

Ans: The Applications covered in the Kidney Cancer Market report are Renal Cell Carcinoma, Renal Pelvis Cancer, Other

What are the Type segmentation covered in the Kidney Cancer Market report?

Ans: The Types covered in the Kidney Cancer Market report are Surgery, Immunotherapy, Targeted Therapy, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Kidney Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Surgery
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.2.5 Other
1.3 Market by Application
1.3.1 Global Kidney Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Renal Cell Carcinoma
1.3.3 Renal Pelvis Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Kidney Cancer Market Perspective (2018-2029)
2.2 Global Kidney Cancer Growth Trends by Region
2.2.1 Kidney Cancer Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Kidney Cancer Historic Market Size by Region (2018-2023)
2.2.3 Kidney Cancer Forecasted Market Size by Region (2024-2029)
2.3 Kidney Cancer Market Dynamics
2.3.1 Kidney Cancer Industry Trends
2.3.2 Kidney Cancer Market Drivers
2.3.3 Kidney Cancer Market Challenges
2.3.4 Kidney Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Kidney Cancer by Players
3.1.1 Global Kidney Cancer Revenue by Players (2018-2023)
3.1.2 Global Kidney Cancer Revenue Market Share by Players (2018-2023)
3.2 Global Kidney Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Kidney Cancer, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Kidney Cancer Market Concentration Ratio
3.4.1 Global Kidney Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Kidney Cancer Revenue in 2022
3.5 Global Key Players of Kidney Cancer Head office and Area Served
3.6 Global Key Players of Kidney Cancer, Product and Application
3.7 Global Key Players of Kidney Cancer, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Kidney Cancer Breakdown Data by Type
4.1 Global Kidney Cancer Historic Market Size by Type (2018-2023)
4.2 Global Kidney Cancer Forecasted Market Size by Type (2024-2029)
5 Kidney Cancer Breakdown Data by Application
5.1 Global Kidney Cancer Historic Market Size by Application (2018-2023)
5.2 Global Kidney Cancer Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Kidney Cancer Market Size (2018-2029)
6.2 North America Kidney Cancer Market Size by Type
6.2.1 North America Kidney Cancer Market Size by Type (2018-2023)
6.2.2 North America Kidney Cancer Market Size by Type (2024-2029)
6.2.3 North America Kidney Cancer Market Share by Type (2018-2029)
6.3 North America Kidney Cancer Market Size by Application
6.3.1 North America Kidney Cancer Market Size by Application (2018-2023)
6.3.2 North America Kidney Cancer Market Size by Application (2024-2029)
6.3.3 North America Kidney Cancer Market Share by Application (2018-2029)
6.4 North America Kidney Cancer Market Size by Country
6.4.1 North America Kidney Cancer Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Kidney Cancer Market Size by Country (2018-2023)
6.4.3 North America Kidney Cancer Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Kidney Cancer Market Size (2018-2029)
7.2 Europe Kidney Cancer Market Size by Type
7.2.1 Europe Kidney Cancer Market Size by Type (2018-2023)
7.2.2 Europe Kidney Cancer Market Size by Type (2024-2029)
7.2.3 Europe Kidney Cancer Market Share by Type (2018-2029)
7.3 Europe Kidney Cancer Market Size by Application
7.3.1 Europe Kidney Cancer Market Size by Application (2018-2023)
7.3.2 Europe Kidney Cancer Market Size by Application (2024-2029)
7.3.3 Europe Kidney Cancer Market Share by Application (2018-2029)
7.4 Europe Kidney Cancer Market Size by Country
7.4.1 Europe Kidney Cancer Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Kidney Cancer Market Size by Country (2018-2023)
7.4.3 Europe Kidney Cancer Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Kidney Cancer Market Size (2018-2029)
8.2 China Kidney Cancer Market Size by Type
8.2.1 China Kidney Cancer Market Size by Type (2018-2023)
8.2.2 China Kidney Cancer Market Size by Type (2024-2029)
8.2.3 China Kidney Cancer Market Share by Type (2018-2029)
8.3 China Kidney Cancer Market Size by Application
8.3.1 China Kidney Cancer Market Size by Application (2018-2023)
8.3.2 China Kidney Cancer Market Size by Application (2024-2029)
8.3.3 China Kidney Cancer Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Kidney Cancer Market Size (2018-2029)
9.2 Asia Kidney Cancer Market Size by Type
9.2.1 Asia Kidney Cancer Market Size by Type (2018-2023)
9.2.2 Asia Kidney Cancer Market Size by Type (2024-2029)
9.2.3 Asia Kidney Cancer Market Share by Type (2018-2029)
9.3 Asia Kidney Cancer Market Size by Application
9.3.1 Asia Kidney Cancer Market Size by Application (2018-2023)
9.3.2 Asia Kidney Cancer Market Size by Application (2024-2029)
9.3.3 Asia Kidney Cancer Market Share by Application (2018-2029)
9.4 Asia Kidney Cancer Market Size by Region
9.4.1 Asia Kidney Cancer Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Kidney Cancer Market Size by Region (2018-2023)
9.4.3 Asia Kidney Cancer Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Kidney Cancer Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Kidney Cancer Market Size by Type
10.2.1 Middle East, Africa, and Latin America Kidney Cancer Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Kidney Cancer Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Kidney Cancer Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Kidney Cancer Market Size by Application
10.3.1 Middle East, Africa, and Latin America Kidney Cancer Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Kidney Cancer Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Kidney Cancer Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Kidney Cancer Market Size by Country
10.4.1 Middle East, Africa, and Latin America Kidney Cancer Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Kidney Cancer Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Kidney Cancer Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Kidney Cancer Introduction
11.1.4 Merck Revenue in Kidney Cancer Business (2018-2023)
11.1.5 Merck Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Kidney Cancer Introduction
11.2.4 Novartis Revenue in Kidney Cancer Business (2018-2023)
11.2.5 Novartis Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Kidney Cancer Introduction
11.3.4 Bristol-Myers Squibb Revenue in Kidney Cancer Business (2018-2023)
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Kidney Cancer Introduction
11.4.4 Pfizer Revenue in Kidney Cancer Business (2018-2023)
11.4.5 Pfizer Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Kidney Cancer Introduction
11.5.4 Roche Revenue in Kidney Cancer Business (2018-2023)
11.5.5 Roche Recent Developments
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Kidney Cancer Introduction
11.6.4 Amgen Revenue in Kidney Cancer Business (2018-2023)
11.6.5 Amgen Recent Developments
11.7 Aveo Pharmaceuticals
11.7.1 Aveo Pharmaceuticals Company Details
11.7.2 Aveo Pharmaceuticals Business Overview
11.7.3 Aveo Pharmaceuticals Kidney Cancer Introduction
11.7.4 Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2018-2023)
11.7.5 Aveo Pharmaceuticals Recent Developments
11.8 Bayer
11.8.1 Bayer Company Details
11.8.2 Bayer Business Overview
11.8.3 Bayer Kidney Cancer Introduction
11.8.4 Bayer Revenue in Kidney Cancer Business (2018-2023)
11.8.5 Bayer Recent Developments
11.9 Exelixis
11.9.1 Exelixis Company Details
11.9.2 Exelixis Business Overview
11.9.3 Exelixis Kidney Cancer Introduction
11.9.4 Exelixis Revenue in Kidney Cancer Business (2018-2023)
11.9.5 Exelixis Recent Developments
11.10 Eisai
11.10.1 Eisai Company Details
11.10.2 Eisai Business Overview
11.10.3 Eisai Kidney Cancer Introduction
11.10.4 Eisai Revenue in Kidney Cancer Business (2018-2023)
11.10.5 Eisai Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Kidney Cancer Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Surgery
    Table 3. Key Players of Immunotherapy
    Table 4. Key Players of Targeted Therapy
    Table 5. Key Players of Other
    Table 6. Global Kidney Cancer Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 7. Global Kidney Cancer Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Kidney Cancer Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Kidney Cancer Market Share by Region (2018-2023)
    Table 10. Global Kidney Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Kidney Cancer Market Share by Region (2024-2029)
    Table 12. Kidney Cancer Market Trends
    Table 13. Kidney Cancer Market Drivers
    Table 14. Kidney Cancer Market Challenges
    Table 15. Kidney Cancer Market Restraints
    Table 16. Global Kidney Cancer Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Kidney Cancer Revenue Share by Players (2018-2023)
    Table 18. Global Top Kidney Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer as of 2022)
    Table 19. Global Kidney Cancer Industry Ranking 2021 VS 2022 VS 2023
    Table 20. Global 5 Largest Players Market Share by Kidney Cancer Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Global Key Players of Kidney Cancer, Headquarters and Area Served
    Table 22. Global Key Players of Kidney Cancer, Product and Application
    Table 23. Global Key Players of Kidney Cancer, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Kidney Cancer Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Kidney Cancer Revenue Market Share by Type (2018-2023)
    Table 27. Global Kidney Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Kidney Cancer Revenue Market Share by Type (2024-2029)
    Table 29. Global Kidney Cancer Market Size by Application (2018-2023) & (US$ Million)
    Table 30. Global Kidney Cancer Revenue Share by Application (2018-2023)
    Table 31. Global Kidney Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 32. Global Kidney Cancer Revenue Share by Application (2024-2029)
    Table 33. North America Kidney Cancer Market Size by Type (2018-2023) & (US$ Million)
    Table 34. North America Kidney Cancer Market Size by Type (2024-2029) & (US$ Million)
    Table 35. North America Kidney Cancer Market Size by Application (2018-2023) & (US$ Million)
    Table 36. North America Kidney Cancer Market Size by Application (2024-2029) & (US$ Million)
    Table 37. North America Kidney Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. North America Kidney Cancer Market Size by Country (2018-2023) & (US$ Million)
    Table 39. North America Kidney Cancer Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Europe Kidney Cancer Market Size by Type (2018-2023) & (US$ Million)
    Table 41. Europe Kidney Cancer Market Size by Type (2024-2029) & (US$ Million)
    Table 42. Europe Kidney Cancer Market Size by Application (2018-2023) & (US$ Million)
    Table 43. Europe Kidney Cancer Market Size by Application (2024-2029) & (US$ Million)
    Table 44. Europe Kidney Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Europe Kidney Cancer Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Europe Kidney Cancer Market Size by Country (2024-2029) & (US$ Million)
    Table 47. China Kidney Cancer Market Size by Type (2018-2023) & (US$ Million)
    Table 48. China Kidney Cancer Market Size by Type (2024-2029) & (US$ Million)
    Table 49. China Kidney Cancer Market Size by Application (2018-2023) & (US$ Million)
    Table 50. China Kidney Cancer Market Size by Application (2024-2029) & (US$ Million)
    Table 51. Asia Kidney Cancer Market Size by Type (2018-2023) & (US$ Million)
    Table 52. Asia Kidney Cancer Market Size by Type (2024-2029) & (US$ Million)
    Table 53. Asia Kidney Cancer Market Size by Application (2018-2023) & (US$ Million)
    Table 54. Asia Kidney Cancer Market Size by Application (2024-2029) & (US$ Million)
    Table 55. Asia Kidney Cancer Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 56. Asia Kidney Cancer Market Size by Region (2018-2023) & (US$ Million)
    Table 57. Asia Kidney Cancer Market Size by Region (2024-2029) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Kidney Cancer Market Size by Type (2018-2023) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Kidney Cancer Market Size by Type (2024-2029) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Kidney Cancer Market Size by Application (2018-2023) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Kidney Cancer Market Size by Application (2024-2029) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Kidney Cancer Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 63. Middle East, Africa, and Latin America Kidney Cancer Market Size by Country (2018-2023) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Kidney Cancer Market Size by Country (2024-2029) & (US$ Million)
    Table 65. Merck Company Details
    Table 66. Merck Business Overview
    Table 67. Merck Kidney Cancer Product
    Table 68. Merck Revenue in Kidney Cancer Business (2018-2023) & (US$ Million)
    Table 69. Merck Recent Developments
    Table 70. Novartis Company Details
    Table 71. Novartis Business Overview
    Table 72. Novartis Kidney Cancer Product
    Table 73. Novartis Revenue in Kidney Cancer Business (2018-2023) & (US$ Million)
    Table 74. Novartis Recent Developments
    Table 75. Bristol-Myers Squibb Company Details
    Table 76. Bristol-Myers Squibb Business Overview
    Table 77. Bristol-Myers Squibb Kidney Cancer Product
    Table 78. Bristol-Myers Squibb Revenue in Kidney Cancer Business (2018-2023) & (US$ Million)
    Table 79. Bristol-Myers Squibb Recent Developments
    Table 80. Pfizer Company Details
    Table 81. Pfizer Business Overview
    Table 82. Pfizer Kidney Cancer Product
    Table 83. Pfizer Revenue in Kidney Cancer Business (2018-2023) & (US$ Million)
    Table 84. Pfizer Recent Developments
    Table 85. Roche Company Details
    Table 86. Roche Business Overview
    Table 87. Roche Kidney Cancer Product
    Table 88. Roche Revenue in Kidney Cancer Business (2018-2023) & (US$ Million)
    Table 89. Roche Recent Developments
    Table 90. Amgen Company Details
    Table 91. Amgen Business Overview
    Table 92. Amgen Kidney Cancer Product
    Table 93. Amgen Revenue in Kidney Cancer Business (2018-2023) & (US$ Million)
    Table 94. Amgen Recent Developments
    Table 95. Aveo Pharmaceuticals Company Details
    Table 96. Aveo Pharmaceuticals Business Overview
    Table 97. Aveo Pharmaceuticals Kidney Cancer Product
    Table 98. Aveo Pharmaceuticals Revenue in Kidney Cancer Business (2018-2023) & (US$ Million)
    Table 99. Aveo Pharmaceuticals Recent Developments
    Table 100. Bayer Company Details
    Table 101. Bayer Business Overview
    Table 102. Bayer Kidney Cancer Product
    Table 103. Bayer Revenue in Kidney Cancer Business (2018-2023) & (US$ Million)
    Table 104. Bayer Recent Developments
    Table 105. Exelixis Company Details
    Table 106. Exelixis Business Overview
    Table 107. Exelixis Kidney Cancer Product
    Table 108. Exelixis Revenue in Kidney Cancer Business (2018-2023) & (US$ Million)
    Table 109. Exelixis Recent Developments
    Table 110. Eisai Company Details
    Table 111. Eisai Business Overview
    Table 112. Eisai Kidney Cancer Product
    Table 113. Eisai Revenue in Kidney Cancer Business (2018-2023) & (US$ Million)
    Table 114. Eisai Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Kidney Cancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Kidney Cancer Market Share by Type: 2022 VS 2029
    Figure 3. Surgery Features
    Figure 4. Immunotherapy Features
    Figure 5. Targeted Therapy Features
    Figure 6. Other Features
    Figure 7. Global Kidney Cancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 8. Global Kidney Cancer Market Share by Application: 2022 VS 2029
    Figure 9. Renal Cell Carcinoma Case Studies
    Figure 10. Renal Pelvis Cancer Case Studies
    Figure 11. Other Case Studies
    Figure 12. Kidney Cancer Report Years Considered
    Figure 13. Global Kidney Cancer Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Kidney Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Kidney Cancer Market Share by Region: 2022 VS 2029
    Figure 16. Global Kidney Cancer Market Share by Players in 2022
    Figure 17. Global Top Kidney Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by Kidney Cancer Revenue in 2022
    Figure 19. North America Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America Kidney Cancer Market Share by Type (2018-2029)
    Figure 21. North America Kidney Cancer Market Share by Application (2018-2029)
    Figure 22. North America Kidney Cancer Market Share by Country (2018-2029)
    Figure 23. United States Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Kidney Cancer Market Size YoY (2018-2029) & (US$ Million)
    Figure 26. Europe Kidney Cancer Market Share by Type (2018-2029)
    Figure 27. Europe Kidney Cancer Market Share by Application (2018-2029)
    Figure 28. Europe Kidney Cancer Market Share by Country (2018-2029)
    Figure 29. Germany Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. France Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. U.K. Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Italy Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Russia Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Nordic Countries Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. China Kidney Cancer Market Size YoY (2018-2029) & (US$ Million)
    Figure 36. China Kidney Cancer Market Share by Type (2018-2029)
    Figure 37. China Kidney Cancer Market Share by Application (2018-2029)
    Figure 38. Asia Kidney Cancer Market Size YoY (2018-2029) & (US$ Million)
    Figure 39. Asia Kidney Cancer Market Share by Type (2018-2029)
    Figure 40. Asia Kidney Cancer Market Share by Application (2018-2029)
    Figure 41. Asia Kidney Cancer Market Share by Region (2018-2029)
    Figure 42. Japan Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. South Korea Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. China Taiwan Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Southeast Asia Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. India Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Australia Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Kidney Cancer Market Size YoY (2018-2029) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Kidney Cancer Market Share by Type (2018-2029)
    Figure 50. Middle East, Africa, and Latin America Kidney Cancer Market Share by Application (2018-2029)
    Figure 51. Middle East, Africa, and Latin America Kidney Cancer Market Share by Country (2018-2029)
    Figure 52. Brazil Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Mexico Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Turkey Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Saudi Arabia Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Israel Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. GCC Countries Kidney Cancer Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 58. Merck Revenue Growth Rate in Kidney Cancer Business (2018-2023)
    Figure 59. Novartis Revenue Growth Rate in Kidney Cancer Business (2018-2023)
    Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Kidney Cancer Business (2018-2023)
    Figure 61. Pfizer Revenue Growth Rate in Kidney Cancer Business (2018-2023)
    Figure 62. Roche Revenue Growth Rate in Kidney Cancer Business (2018-2023)
    Figure 63. Amgen Revenue Growth Rate in Kidney Cancer Business (2018-2023)
    Figure 64. Aveo Pharmaceuticals Revenue Growth Rate in Kidney Cancer Business (2018-2023)
    Figure 65. Bayer Revenue Growth Rate in Kidney Cancer Business (2018-2023)
    Figure 66. Exelixis Revenue Growth Rate in Kidney Cancer Business (2018-2023)
    Figure 67. Eisai Revenue Growth Rate in Kidney Cancer Business (2018-2023)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Gene Therapy For Cancer Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22G13317
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Cancer Biomarkers Detection Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-30Q5590
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Oncology Companion Diagnostic Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14K8500
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Throat Cancer Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-8R8713
Fri Feb 23 00:00:00 UTC 2024

Add to Cart